"We found that some cancer types responded extremely well to the immunotherapy, including colon and stomach cancer," ...

Emma Weston joined the clinical trial after running out of treatment options. For two years, she's been cancer free.

A young woman is expressing her gratitude for a lifesaving clinical trial, while doctors hold their breath over the potential for federal funding cuts. After years of surgery, chemotherapy and ...

Some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, ...

Participants in the trial were all patients with tumors ranging from stage 1 to stage 3, meaning the tumors had not yet spread, the release indicated.

Bianca Harvey lived a healthy and athletic lifestyle and was shocked to be diagnosed with colon cancer at 33. Now, she vows ...

Neoadjuvant PD-1 blockade with dostarlimab achieved high rates of organ preservation in patients with early-stage mismatch ...

A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.

A "groundbreaking" cancer treatment trial by Memorial Sloan Kettering shows immunotherapy alone can eliminate some tumors, ...

New results from a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK), gastrointestinal oncologists Andrea ...